As of Jun 27
| -0.07 / -1.62%|
The 1 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +64.32% increase from the last price of 4.26.
The current consensus among 1 polled investment analysts is to Hold stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.